136 related articles for article (PubMed ID: 14870789)
1. Evaluation of circulating calcitonin: analytical aspects.
Martinetti A; Seregni E; Ferrari L; Pallotti F; Aliberti G; Coliva A; Fracassi S; Bombardieri E
Tumori; 2003; 89(5):566-8. PubMed ID: 14870789
[TBL] [Abstract][Full Text] [Related]
2. Critical aspects of immunoradiometric thyroglobulin assays.
Ferrari L; Biancolini D; Seregni E; Aliberti G; Martinetti A; Villano C; Pallotti F; Chiesa C; Bombardieri E
Tumori; 2003; 89(5):537-9. PubMed ID: 14870780
[TBL] [Abstract][Full Text] [Related]
3. Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer.
Kratzsch J; Petzold A; Raue F; Reinhardt W; Bröcker-Preuss M; Görges R; Mann K; Karges W; Morgenthaler N; Luster M; Reiners C; Thiery J; Dralle H; Fuhrer D
Clin Chem; 2011 Mar; 57(3):467-74. PubMed ID: 21159900
[TBL] [Abstract][Full Text] [Related]
4. Validation, role in perioperative assessment, and clinical applications of an immunoradiometric assay for human calcitonin.
Wimalawansa SJ; Bailey F
Peptides; 1995; 16(2):307-12. PubMed ID: 7784260
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease.
Herrmann BL; Schmid KW; Goerges R; Kemen M; Mann K
Eur J Endocrinol; 2010 Jun; 162(6):1141-5. PubMed ID: 20332126
[TBL] [Abstract][Full Text] [Related]
6. Treatment evaluation, follow-up and familial screening of medullary thyroid carcinoma by highly specific calcitonin measurements.
Ainahi A; Kebbou M; Timinouni M; Benabdeljalil N; Oufara S
Indian J Cancer; 2006; 43(2):75-9. PubMed ID: 16790944
[TBL] [Abstract][Full Text] [Related]
7. Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
[No Abstract] [Full Text] [Related]
8. Performance evaluation of an automated electrochemiluminescent calcitonin (CT) immunoassay in diagnosis of medullary thyroid carcinoma.
Schiettecatte J; Strasser O; Anckaert E; Smitz J
Clin Biochem; 2016 Aug; 49(12):929-31. PubMed ID: 27182955
[TBL] [Abstract][Full Text] [Related]
9. Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma.
Algeciras-Schimnich A; Preissner CM; Theobald JP; Finseth MS; Grebe SK
J Clin Endocrinol Metab; 2009 Mar; 94(3):861-8. PubMed ID: 19088163
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of an immunoassay for calcitonin].
Sylla Niang M; Lombardo F; Schlumberger M; Bidart JM
Dakar Med; 2008; 53(1):76-83. PubMed ID: 19102121
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
[TBL] [Abstract][Full Text] [Related]
12. [Calcitonin determination for early diagnosis of medullary thyroid cancer].
Karges W
Chirurg; 2010 Jul; 81(7):620, 622-6. PubMed ID: 20549176
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin precursor levels in human medullary thyroid carcinoma.
Bihan H; Becker KL; Snider RH; Nylen E; Vittaz L; Lauret C; Modigliani E; Moretti JL; Cohen R
Thyroid; 2003 Aug; 13(8):819-22. PubMed ID: 14558925
[TBL] [Abstract][Full Text] [Related]
14. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal immunoradiometric assay of calcitonin improves investigation of familial medullary thyroid carcinoma.
Perdrisot R; Bigorgne JC; Guilloteau D; Jallet P
Clin Chem; 1990 Feb; 36(2):381-3. PubMed ID: 2302785
[TBL] [Abstract][Full Text] [Related]
16. Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin.
Bieglmayer C; Scheuba C; Niederle B; Flores J; Vierhapper H
Wien Klin Wochenschr; 2002 Apr; 114(7):267-73. PubMed ID: 12089862
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin levels by ECLIA correlate well with RIA values in higher range but are affected by sex, TgAb, and renal function in lower range.
Ito Y; Kaneko H; Sasaki Y; Ohana N; Ichijo M; Furuya F; Suzuki S; Suzuki S; Shimura H
Endocr J; 2020 Jul; 67(7):759-770. PubMed ID: 32269183
[TBL] [Abstract][Full Text] [Related]
18. Basal and pentagastrin-stimulated calcitonin cut-off values in diagnosis of preoperative medullary thyroid cancer.
Kartal Baykan E; Erdoğan M
Turk J Med Sci; 2021 Apr; 51(2):650-656. PubMed ID: 33128357
[TBL] [Abstract][Full Text] [Related]
19. Analytical quality of calcitonin determination and its effect on the adequacy of screening for medullary carcinoma of the thyroid.
Cavalier E; Carlisi A; Chapelle JP; Delanaye P
Clin Chem; 2008 May; 54(5):929-30. PubMed ID: 18443183
[No Abstract] [Full Text] [Related]
20. Basal calcitonin levels and the response to pentagastrin stimulation in patients after kidney transplantation or on chronic hemodialysis as indicators of medullary carcinoma.
Kotzmann H; Schmidt A; Scheuba C; Kaserer K; Watschinger B; Söregi G; Niederle B; Vierhapper H
Thyroid; 1999 Sep; 9(9):943-7. PubMed ID: 10524574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
